Express Pharma

Eli Lilly pauses trial of antibody drug for COVID-19 over safety concern

The company had said earlier this month that it was applying for EUA for the antibody-drug, LY-CoV555, for patients with mild to moderate COVID-19 based on data from another clinical trial

0 287